Mirae Asset Global Investments Co. Ltd. Increases Stock Holdings in Unum Group (NYSE:UNM)

Mirae Asset Global Investments Co. Ltd. grew its position in shares of Unum Group (NYSE:UNM - Free Report) by 13.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 127,163 shares of the financial services provider's stock after purchasing an additional 14,890 shares during the quarter. Mirae Asset Global Investments Co. Ltd. owned approximately 0.07% of Unum Group worth $9,307,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Capital Performance Advisors LLP acquired a new position in Unum Group in the 3rd quarter valued at approximately $31,000. Thurston Springer Miller Herd & Titak Inc. bought a new position in Unum Group during the 3rd quarter worth $37,000. V Square Quantitative Management LLC raised its position in Unum Group by 38.2% during the 3rd quarter. V Square Quantitative Management LLC now owns 702 shares of the financial services provider's stock worth $42,000 after purchasing an additional 194 shares during the last quarter. Quarry LP lifted its holdings in Unum Group by 4,794.7% during the 3rd quarter. Quarry LP now owns 930 shares of the financial services provider's stock worth $55,000 after buying an additional 911 shares during the period. Finally, Versant Capital Management Inc increased its stake in shares of Unum Group by 26.4% in the fourth quarter. Versant Capital Management Inc now owns 766 shares of the financial services provider's stock valued at $56,000 after buying an additional 160 shares during the period. 86.57% of the stock is currently owned by institutional investors.

Insider Transactions at Unum Group

In related news, EVP Timothy Gerald Arnold sold 10,000 shares of the stock in a transaction dated Wednesday, November 27th. The shares were sold at an average price of $76.92, for a total transaction of $769,200.00. Following the completion of the transaction, the executive vice president now owns 54,827 shares in the company, valued at approximately $4,217,292.84. This represents a 15.43 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Hanley Ronald P. O sold 14,299 shares of Unum Group stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $72.10, for a total transaction of $1,030,957.90. Following the completion of the sale, the director now directly owns 38,819 shares in the company, valued at approximately $2,798,849.90. This represents a 26.92 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 98,164 shares of company stock worth $7,346,040 in the last quarter. 0.93% of the stock is currently owned by corporate insiders.

Unum Group Stock Up 0.1 %

UNM stock traded up $0.11 during trading on Monday, reaching $77.06. 438,714 shares of the stock were exchanged, compared to its average volume of 1,110,739. The company has a current ratio of 0.29, a quick ratio of 0.28 and a debt-to-equity ratio of 0.32. Unum Group has a twelve month low of $47.65 and a twelve month high of $79.43. The firm's 50 day moving average is $74.23 and its 200 day moving average is $65.49. The firm has a market cap of $14.07 billion, a P/E ratio of 8.15, a price-to-earnings-growth ratio of 1.17 and a beta of 0.80.

Unum Group (NYSE:UNM - Get Free Report) last released its quarterly earnings data on Tuesday, February 4th. The financial services provider reported $2.03 earnings per share for the quarter, missing analysts' consensus estimates of $2.14 by ($0.11). Unum Group had a net margin of 13.81% and a return on equity of 14.91%. As a group, research analysts forecast that Unum Group will post 9.12 EPS for the current year.

Unum Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Friday, January 24th will be given a dividend of $0.42 per share. The ex-dividend date of this dividend is Friday, January 24th. This represents a $1.68 annualized dividend and a dividend yield of 2.18%. Unum Group's payout ratio is 17.74%.

Analyst Ratings Changes

A number of equities analysts recently commented on the company. Jefferies Financial Group lifted their price objective on Unum Group from $91.00 to $96.00 and gave the stock a "buy" rating in a research note on Tuesday, December 10th. BMO Capital Markets began coverage on shares of Unum Group in a research report on Thursday, January 23rd. They issued an "outperform" rating and a $91.00 price target on the stock. Evercore ISI upgraded shares of Unum Group from an "in-line" rating to an "outperform" rating and increased their price objective for the stock from $67.00 to $84.00 in a research report on Thursday, November 14th. Truist Financial boosted their target price on shares of Unum Group from $70.00 to $75.00 and gave the company a "buy" rating in a report on Friday, November 1st. Finally, Piper Sandler increased their price target on Unum Group from $82.00 to $87.00 and gave the stock an "overweight" rating in a report on Thursday. Five research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $79.45.

Unum Group Company Profile

Unum Group, together with its subsidiaries, provides financial protection benefit solutions primarily in the United States, the United Kingdom, Poland, and internationally. It operates through Unum US, Unum International, Colonial Life, and Closed Block segment. The company offers group long-term and short-term disability, group life, and accidental death and dismemberment products; supplemental and voluntary products, such as individual disability, voluntary benefits, and dental and vision products; and accident, sickness, disability, life, and cancer and critical illness products.